Nuclear Regulatory Commission November 16, 2015 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Rare Element Resources, Inc.; Bear Lodge Project
The U.S. Nuclear Regulatory Commission (NRC) has received an application from Rare Element Resources, Inc., for a license to possess and use source material associated with its Bear Lodge Project. The Bear Lodge Project includes a mine in the Black Hills National Forest in Crook County, Wyoming for the purpose of extracting rare earth element ores, and a rare earth element processing plant in Weston County, Wyoming. In addition, the license application contains sensitive unclassified non-safeguards information (SUNSI).
Preparing and Reviewing Licensing Applications for Instrumentation and Control Systems for Non-Power Reactors
The U.S. Nuclear Regulatory Commission (NRC) is requesting public comment on draft Chapter 7, ``Instrumentation and Control Systems,'' which augments the following: (1) NUREG-1537, Part 1, ``Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content;'' and (2) NUREG-1537, Part 2, ``Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria.'' This draft chapter of NUREG-1537 provides revised guidance for preparing and reviewing applications for instrumentation and control systems.
Sodium Iodide-131 Patient Release Information Collection
The U.S. Nuclear Regulatory Commission (NRC) is requesting information from the general public on a number of issues associated with medical treatment of patients with sodium iodide I-131 (hereafter referred to as I-131). Specifically, the NRC would like input on patient concerns about medical treatment involving the use of I-131, information that physicians use to make decisions on when it is safe to release I-131 patients based on radiation exposure concerns, radiation safety information used by I-131 patients after their release, and the availability of a radiation safety informational guidance brochure for I-131 patients that can be distributed nationwide. The information collected will be used to develop a Web site to provide patients with clear and consistent information about radioactive iodine treatments and to revise NRC patient release guidance.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.